Corrected: 'A piece of plastic with a 40-year-old drug in it': J&J touts promising early data for bladder cancer treatment
This story was corrected to reflect updated data with a later cutoff date.
In an early cut of data, Johnson & Johnson said Sunday afternoon that 16 of 22 patients who received its experimental bladder cancer treatment — a decades-old chemotherapy delivered in a device which its developers call “the pretzel” — saw their tumors go away.
The Phase II study, known as SunRISe-1, looked at patients with non–muscle-invasive bladder cancer (meaning that their cancer has not infiltrated their bladder wall) who did not respond to Bacillus Calmette-Guérin, or BCG, the standard-of-care treatment.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.